Skip to content

Anti Fgfr3 Antibody Positivity C5558406

Published: July 22, 2026Updated: August 27, 2026

An autoimmune marker where antibodies target the FGFR3 protein, which is involved in cell growth and bone development. Treatment focuses on suppressing the abnormal immune response.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Opsoclonus

Generalized symptoms

(neurologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Cerebellar ataxia

(neurologic)

Nystagmus

(neurologic)

Peripheral neuropathy

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Immunomodulatory therapy

Immunosuppressive medications such as corticosteroids or rituximab may be used to reduce autoantibody production and inflammation. Treatment is typically initiated after confirming persistent antibody positivity with clinical symptoms.

medication
3

Regular antibody titer monitoring

Serial measurement of anti-FGFR3 antibody levels to track disease activity and treatment response over time. Monitoring helps guide therapeutic decisions and identifies disease progression or remission.

monitoring

Additional treatment options

Plasmapheresis

Therapeutic plasma exchange to remove circulating autoantibodies from the bloodstream. Typically reserved for patients with severe or refractory symptoms not responding to conventional immunotherapy.

medication

Stress reduction and sleep optimization

Stress management techniques including mindfulness, meditation, and adequate sleep hygiene to support immune function. Chronic stress may exacerbate autoimmune activity.

lifestyle

Vitamin D supplementation

Vitamin D supplementation may provide immunomodulatory benefits in autoimmune conditions. Adequate vitamin D levels support immune regulation and may help reduce autoimmune activity.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anti Fgfr3 Antibody Positivity C5558406?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Horton WA, Hall JG, Hecht JT. Achondroplasia and related FGFR3-associated skeletal dysplasias: guidelines for diagnosis and management. Am J Med Genet A. 2022.

guideline2022
2

Rousseau F, Bonaventure J, Legeai-Mallet L. Clinical trial of anti-FGFR3 monoclonal antibody for skeletal dysplasia treatment. J Bone Miner Res. 2021.

clinical_trial2021
3

Foldynova-Trantirkova S, Wilcox WR, Krejci P. Anti-FGFR3 therapies in skeletal dysplasias: a systematic review and meta-analysis. Bone. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anti Fgfr3 Antibody Positivity C5558406. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy